Tasonermin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11626 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | prostatic urethra urothelial carcinoma | KG + DL |
| 2 | kidney pelvis sarcomatoid transitional cell carcinoma | KG + DL |
| 3 | infiltrating bladder urothelial carcinoma sarcomatoid variant | KG + DL |
| 4 | renal pelvis papillary urothelial carcinoma | KG + DL |
| 5 | HER2 positive breast carcinoma | KG + DL |
| 6 | uterine ligament adenocarcinoma | KG + DL |
| 7 | endocervical carcinoma | KG + DL |
| 8 | uterine ligament serous adenocarcinoma | KG + DL |
| 9 | adenoid cystic carcinoma of the cervix uteri | KG + DL |
| 10 | uterine ligament clear cell adenocarcinoma | KG + DL |
| 11 | signet ring cell variant cervical mucinous adenocarcinoma | KG + DL |
| 12 | cervical adenosquamous carcinoma, glassy cell variant | KG + DL |
| 13 | uterine ligament mucinous adenocarcinoma | KG + DL |
| 14 | uterine ligament endometrioid adenocarcinoma | KG + DL |
| 15 | endocervical type cervical mucinous adenocarcinoma | KG + DL |
| 16 | cervical mucinous adenocarcinoma, minimal deviation variant | KG + DL |
| 17 | intestinal variant cervical mucinous adenocarcinoma | KG + DL |
| 18 | progesterone-receptor negative breast cancer | KG + DL |
| 19 | normal breast-like subtype of breast carcinoma | KG + DL |
| 20 | progesterone-receptor positive breast cancer | KG + DL |
| 21 | breast tumor luminal A or B | KG + DL |
| 22 | transitional cell carcinoma | KG + DL |
| 23 | nasopharyngeal teratoma | KG + DL |
| 24 | benign neoplasm of hypopharynx | KG + DL |
| 25 | epiglottis neoplasm | KG + DL |
| 26 | angiosarcoma of the scalp | KG + DL |
| 27 | pre-malignant neoplasm | KG + DL |
| 28 | benign neoplasm of tongue | KG + DL |
| 29 | nasal cavity inverting papilloma | KG + DL |
| 30 | malignant ear neoplasm | KG + DL |
| 31 | benign neoplasm of floor of mouth | KG + DL |
| 32 | inner ear neoplasm | KG + DL |
| 33 | benign neoplasm of nasal cavity | KG + DL |
| 34 | neoplasm of major salivary gland | KG + DL |
| 35 | jugular foramen meningioma | KG + DL |
| 36 | schwannoma of jugular foramen | KG + DL |
| 37 | cystic neoplasm | KG + DL |
| 38 | cervical neuroblastoma | KG + DL |
| 39 | ocular cancer | KG + DL |
| 40 | benign neoplasm of buccal mucosa | KG + DL |
| 41 | spinal accessory nerve neoplasm | KG + DL |
| 42 | facial nerve neoplasm | KG + DL |
| 43 | trochlear nerve neoplasm | KG + DL |
| 44 | odontogenic cyst | KG + DL |
| 45 | vestibulocochlear nerve neoplasm | KG + DL |
| 46 | benign neoplasm of salivary gland | KG + DL |
| 47 | trophoblastic neoplasm | KG + DL |
| 48 | benign neoplasm of oral cavity | KG + DL |
| 49 | external ear neoplasm | KG + DL |
| 50 | mesenchymoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.